Charm Therapeutics

View the org chart displaying its 11 main executives

Most searched biographies at Charm Therapeutics

• Laksh Aithani, Chief Executive Officer
• Nihal Sinha, Director
• Muz Mansuri, Director

Popular executive movements at Charm Therapeutics

• Nicholas Edmunds has joined the company as Chief Development Officer and Head of Pre-Clinical Development  (posted on May 2 2024).
• Laura Hare has joined the company as Chief People Officer and Head of Business Operations  (posted on December 12 2023).
• Sarah Skerratt, who was Senior Vice President and Head of Drug Discovery, is promoted to Chief Scientific Officer  (posted on December 12 2023).

Create your alert
to follow the executive moves at Charm Therapeutics.

Charm Therapeutics has 2,291 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
• Bluejay Therapeutics has just announced a $182 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Charm Therapeutics

• Press Release Archives - Charm Therapeutics

Social media about Charm Therapeutics

• Charm Therapeutics on Wikipedia, Google News & Yahoo Finance
• Charm Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Laksh Aithani

Call Charm Therapeutics at +44 793...

View the org chart

Register to receive your alert

Report an error